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INTRODUCTION 
Traditionally, maximal therapeutic efficacy and minimal toxicity 
of drugs have been the primary considerations in antimicrobial 
therapy. Selection of medications for patients was based on consider 
ations of efficacy and toxicity of a particular drug as compared to 
its alternatives, and since third-party carriers readily provided 
reimbursement, hospitals enjoyed considerable freedom in determina-
tion of their charges to patients. 
With rapidly rising health care costs in the 1970s, a change in 
the reimbursement system occurred. Beginning in 1983, a prospective 
system of reimbursement was implemented, categorized by diagnostic-
related groups (DRGs). This change and the recent introduction of 
several new cephalosporins have led to more careful consideration of 
the cost of alternative medications used in the treatment of patients 
The importance of appropriate drug selection can be illustrated 
by the ever increasing number of cephalosporins available. Three 
generations of this drug class are in clinical use, with both group 
and individual differences in antimicrobial spectrum of activity, 
pharmacokinetics and adverse effects. Although the newest cephalo-
sporins are considerably more expensive than first-generation 
cephalosporins, claims of cost savings often are made since many of 
the newer agents may be administered less frequently than their 
predecessors. To determine whether less frequent dosing results in 
cost savings, factors other than the acquisition cost of the drug 
alone must be taken into account. Although researchers began to 
examine the aggregate costs of drug therapy in the 1970s, not until 
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the 1980s did investigators closely study these factors and make 
comparisons of different drug regimens. 
BACKGROUND 
Klimek and colleagues were among the first to examine comprehen-
sive costs involved in antibiotic therapy.''' They compared cefazolin 
and cephalothin using administration and drug acquisition costs as 
variable factors, and concluded that cefazolin would save $4.97 per 
patient at their institution because of less frequent dosing require-
ments and the use of the bolus injection route of administration 
rather than intermittent infusion as required with cephalothin. 
Scheife et al. in 1981 compared the costs of cefoxitin to a 
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combination of clindamycin and amikacin. In calculating costs to 
the patient they considered drug cost using the price-allocation 
method and a sterile products charge of $1 for each intravenous 
infusion. They found the cost of cefoxitin to the patient to be 
nearly $43 a day, whereas clindamycin and amikacin were slightly over 
$56 a day. 
Rapp and colleagues in 1982 compared the cost of single-agent 
and combination-agent antimicrobial therapy in the prophylaxis and 
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treatment of hospitalized patients. They conducted one of the first 
studies which considered antibiotic cost, supplies, laboratory 
monitoring, and personnel time involved in the preparation and 
administration of the drug (pharmacy and nursing costs) . One group 
of 30 patients received a first-generation cephalosporin while the 
second group of 30 patients received multiple antibiotics including 
an aminoglycoside plus a penicillin, cephalosporin or clindamycin. 
Calculation of the total costs from the variables described above 
indicated that combination therapy was nearly four times the cost of 
single-agent treatment ($428 versus $111). 
Dudley and Barriere, also in 1982, suggested that acquisition 
cost, not patient charges, should be the basis on which costs of drug 
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therapy be compared. They compared the costs of several antibiotic 
regimens: 1 gram doses of nafcillin, oxacillin or cephalothin given 
intravenously every four hours compared to 1 gram of cefazolin given 
intravenously or intramuscularly every eight hours. The authors used 
patient charges to calculate the cost differences, and did not break 
down personnel costs, supplies, or laboratory monitoring. Despite 
this, they concluded that cefazolin intravenously or intramuscularly 
was significantly less expensive than the other antibiotics studied. 
Cefazolin could result in a savings from two dollars to one hundred 
forty-nine dollars if given intravenously and seven dollars to two 
hundred one dollars if given intramuscularly at their institution. 
Suzuki and Pelham studied the effect of pharmacist monitoring on 
costs of cefazolin therapy in 1983.^ They determined the cost of 
materials used (antibiotic and supplies) and personnel costs (pharma-
cists, nurses, technicians). The authors found that when pharmacists 
monitored therapy, the dosage regimens ordered were more appropriate, 
with administration generally every eight hours instead of every six. 
Significant savings in material costs and personnel time were achiev-
ed. Even with the added time spent by pharmacists in consultation, 
the calculated material and personnel savings could have amounted to 
over $22,000 annually in their institution. 
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Tanner in 1984 identified the steps involved in the preparation, 
dispensing and administration of intravenous antibiotics at several 
institutions.^ He assigned supply and personnel costs to each vari-
able step, as appropriate. Using this information, Tanner could more 
accurately compare the true costs of two different methods of anti-
biotic administration. 
Eisenberg and colleagues conducted a detailed investigation to 
determine whether cefonicid, a third-generation cephalosporin with a 
long half-life, would be less expensive to use than older cephalo-
sporins requiring multiple daily dosing.^ They also identified the 
variables involved in drug therapy after acquisition, including 
administration, fixed and variable costs, and the time spent at each 
step. They then assigned dollar costs to each component of the 
process and compared once daily administration to multiple daily 
dosing. Their analysis included four hospitals of varying sizes. 
The results indicated that cefonicid would result in more savings 
than would the use of older cephalosporins; from $3.70 to $7.20 per 
patient day, depending on the institution. This was attributed to a 
decrease in time spent for reconstitution, preparation and adminis-
tration of the drug. 
Parr et al. compared seven antibiotic regimens in a simulated 
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patient using a computer model. The investigators identified the 
steps involved in antibiotic preparation including administration, 
material and personnel costs. They also accounted for laboratory 
costs and time spent by pharmacists in monitoring drug therapy. 
Analysis of costs demonstrated that a combination of ticarcillin plus 
gentamicin would be 36% of the cost of a course of therapy with 
moxalactam and piperacillin in their institution ($908 versus $2543). 
The drug and material costs contributed more significantly to the 
final cost than did personnel costs. 
McCue in 1986 reported that several factors besides drug cost 
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contribute significantly to the hospital charges for a drug. In the 
hospitals he studied, these included the following: markups, averag-
ing 134.5%; dispensing fees, averaging $5; piggyback administration 
charges, averaging $9; and labor and monitoring, including pharmacist 
consultation and laboratory tests. 
The investigators cited above have attempted to define the costs 
of drug therapy, beginning with a simple dollar per gram figure to 
complex models detailing all the steps from acquisition through moni-
toring and assigning dollar amounts to those variables. Until 
recently, however, there has not been a consistent method to calculate 
all of the costs of antimicrobial therapy by the various researchers. 
OBJECTIVES 
The objectives of this study were the following: 1) identifica-
tion of the steps involved in providing antibiotic therapy, from 
acquisition through administration and monitoring; 2) measurement of 
the time spent at each step, and the costs generated by these steps; 
3) calculation of the total costs for a given antibiotic regimen. 
The model chosen included comparisons of ceftriaxone and cefuroxime 
to standard regimens of ampicillin plus chloramphenicol for the 
treatment of pediatric Haemophilus influenzae meningitis. 
Ampicillin and chloramphenicol are considered the standard 
antibiotic regimen for treatment of Haemophilus influenzae meningitis. 
Due to increasing resistance of this organism to ampicillin, initial 
therapy includes ampicillin plus chloramphenicol, or chloramphenicol 
alone. When sensitivities are obtained, the patient may then con-
tinue treatment with a single appropriate antibiotic. 
Ceftriaxone is a recently released third-generation cephalo-
sporin with a spectrum of activity which includes beta-lactamase 
positive Haemophilus influenzae. In the presence of meningeal 
inflammation, ceftriaxone penetrates well into the cerebrospinal 
fluid and has a comparatively long half-life of eight hours, which 
allows for once or twice daily dosing. Studies indicate that ceftri-
axone may be as efficacious as traditional antibiotic therapy for 
Haemophilus influenzae meningitis.^'^ 
Cefuroxime is a second-generation cephalosporin which also has 
good cerebrospinal fluid penetration in the presence of meningeal 
inflammation and a half-life of 1.3 hours; it is dosed every eight 
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hours. Cefuroxime has been successfully used to treat Haemophilus 
influenzae meningitis also. Since both of these antibiotics require 
less frequent dosing than the ampicillin/chloramphenicol regimen, 
which are administered six and four times daily, respectively, it is 
reasonable to ask if these antibiotics would be cost-effective 
alternatives for treatment. 
METHODS 
The method used to conduct this study was similar to that 
described in earlier cost comparison analyses, consisting of the 
following steps: 1) selection of the hospitals to be included in the 
sample; 2) identification of the process followed in drug acquisi-
tion, preparation, dispensing, administration, monitoring, and the 
relationships among these steps; 3) determination of which of these 
components varied with respect to dosing frequency of the antibiotic; 
4) determination of fixed and variable costs in this process; 5) 
determination from hospital records of the usual dosing frequencies 
of ampicillin and chloramphenicol that would be compared to ceftri-
axone and cefuroxime; 6) selection of the method to measure resources 
used and time spent on variable steps; 7) actual measurement of 
material and personnel expenditures for each identified variable 
factor; 8) assignment of dollar costs to the resources and time 
spent on each step; 9) enumeration of all cost components for each 
antibiotic regimen in the analysis. 
Study Sites 
The hospitals chosen for this analysis were Primary Children's 
Medical Center in Salt Lake City, Utah and Children's Memorial 
Hospital in Chicago, Illinois, 180-bed and 265-bed institutions, 
respectively. These facilities were selected since they were 
expected to use different systems of acquisition, compounding, and 
administration of medications. 
Processing of a Therapeutic Agent: The Steps Taken From Acquisition 
Through Monitoring 
By interviewing the appropriate personnel, the pathway of the 
medication from its acquisition through monitoring could be traced. 
The steps identified are similar to those described by Eisenberg et 
al.^ Acquisition consisted of placement of the drug order, its 
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receipt and storage. Preparation included processing of the medica-
tion order (checking for appropriateness, entry into the patient 
profile, generation of labels), assembly of materials for compound-
ing, reconstitution of antibiotic solutions and delivery to the 
patient care area. Administration of the drug required checking of 
the order against the medication, verification of the antibiotic 
solution for correctness, and infusion of the antibiotic. With 
regard to monitoring, this included checking chloramphenicol serum 
concentrations and any recommendations made by a pharmacist concern-
ing therapy (Table 1). From these steps, the factors which varied 
with dosing frequency could be identified. These variable costs 
included the amount of drug used, wastage, diluent, syringes and 
tubing. Fixed costs or overhead were costs that did not vary with 
respect to the dosing frequency, and consisted of capital equipment 
and inventory (Table 2). 
Material and Personnel Costs 
For each variable component as described above, it was necessary 
to consider material and personnel costs. The studies by Eisenberg, 
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Parr and Reilly described items they included in these costs. ' ' 
For this analysis, material costs included the antibiotic and any 
supplies needed in its compounding such as syringes, diluent, tubing 
and administration sets. Personnel costs consisted of the salaries 
of buyers, technicians, nurses and pharmacists (Table 2). 
Dosing Frequencies of Ampicillin and Chloramphenicol 
The hospital records from each institution revealed the dosing 
frequencies of ampicillin and chloramphenicol at the respective 
facilities. These frequencies were used in the design of the 
regimens to be compared, as follows: 1) ampicillin 300mg/kg/d, given 
intravenously every four hours, plus chloramphenicol lOOmg/kg/d, 
given intravenously every six hours; 2) chloramphenicol lOOmg/kg/d, 
given intravenously every six hours; 3) ceftriaxone lOOmg/kg/d, 
given intravenously every 12 hours; 4) cefuroxime lOOmg/kg/d, given 
intravenously every eight hours (Table 3). A ten-day course of 
therapy in a ten kilogram child was assumed in the calculation of the 
total costs of the various regimens. 
Data Collection 
The method of data collection consisted of management engineer-
ing studies at each selected variable step. Thirty samples of the 
following parameters were to be collected: processing of orders in 
the pharmacy, antibiotic reconstitution, delivery to the floor, and 
administration. It was assumed that the following activities did not 
vary significantly with respect to time, therefore only one time 
observation was taken: drug ordering from the distributor, physician 
order writing, materials ordering from central supply, and shelving 
of delivered stock (Table 4). Material expenditure and personnel 
time spent on an activity were recorded for each of these variables. 
Once these values were known, the following equations, adapted from 
Eisenberg, were used in calculation of the cost components: 
Material costs = (unit cost of resource) x (number of units 
of resource consumed) 
Personnel costs = (hourly wage including benefits) x (time 
spent on a given function) 
To calculate indirect costs for pharmacy and nursing, the following 
equations were used: 
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PHARMACY: 
Allocated indirect allocated indirect cost x injectable volume 
cost per unit per day total volume/365 
Fixed cost per day = constant hours x hourly wage for fixed staff 
By adding the above two equations and dividing the total by 24, a 
calculation of allocated and fixed staff cost per hour can be 
obtained. 
NURSING: 
Allocated indirect allocated indirect cost x unit beds 
cost per unit per day total beds/365 
Fixed cost per day = constant hours x hourly wage for fixed staff 
By adding the above two equations and dividing the total by 24, a 
calculation of allocated and fixed staff cost per hour can be 
obtained. 
Enumeration of Cost Components 
Addition of the variable costs and drug costs and an accounting 
for the dosing frequencies in each regimen yielded the final enumera-
tion of the total cost. Statistical analysis included a one-way 
analysis of variance to determine if there was a significant differ-
ence in cost among the various regimens. 
RESULTS 
The historical dosing frequencies of ampicillin and chloram-
phenicol were determined from hospital records. In both facilities 
ampicillin was administered intravenously every four hours for 
pediatric meningitis patients, and chloramphenicol was administered 
intravenously every six hours. Ceftriaxone and cefuroxime were 
administered every twelve and every eight hours, respectively. These 
dosing intervals were used to determine the total costs of a given 
regimen. Tables 5,6,8-12,14,15,17-20 depict the data collected at 
Children's Memorial Hospital and Primary Children's Medical Center 
for each antibiotic studied. The overall process was the same at 
each institution, however the individual steps were delineated in 
more detail in the data analysis at Primary Children's Medical Center 
due to time constraints while collecting data in Chicago. 
At Primary Children's Medical Center labor and supply costs 
varied in direct proportion to dosing frequency (Table 13). Ceftri-
axone was the least expensive antibiotic in terms of labor and 
supplies, these values being $26.70 and $1.58 per day, respectively. 
Cefuroxime had associated labor costs of $34.01 and supplies added 
$2.15 per day. Chloramphenicol cost $35.64 per day in labor, with 
supplies another $2.58. Ampicillin was the most expensive antibiotic 
based on these measurements. Labor costs for ampicillin were $44.24 
daily and supplies were an additional $3.82 per day. The drug costs 
of the antibiotics frequently offset the costs just mentioned. 
Ampicillin and chloramphenicol were by far the least expensive anti-
biotics, $2.10 and $.80 per gram, respectively. Cefuroxime cost 
$6.60 per gram and ceftriaxone was almost four times as expensive at 
$22.90 per gram. 
The total costs of therapy were calculated assuming a ten-day 
course of intravenous therapy, using the daily dosages described in 
the methods section. For a ten kilogram child, a course of treatment 
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with chloramphenicol was calculated to be $390.20, with cefuroxime 
$427.60, and with the combination of ampicillin and chloramphenicol 
$498.92. Ceftriaxone was the most expensive antibiotic with a cost 
of $511.80. These figures indicate that for Primary Children's 
Medical Center, chloramphenicol would be the least expensive anti-
biotic to use for the treatment of meningitis. 
At Children's Memorial Hospital in Chicago, labor costs also 
varied directly with dosing frequency, as seen in Table 21. Ceftri-
axone was the least expensive antibiotic with labor costs of $39.90 
daily. Cefuroxime cost $49.60 per day and ampicillin was the most 
expensive antibiotic at $69.31 daily. Chloramphenicol was not used 
at Children's Memorial Hospital, having been completely replaced by 
cephalosporins for the treatment of meningitis. The cost of supplies 
also varied directly with dosing frequency, being $0.79 per day for 
ceftriaxone, $1.21 for cefuroxime and $1.81 for ampicillin. The 
costs of the drugs were similar to those at Primary Children's 
Medical Center; $2.40 per gram of ampicillin, $7.10 per gram of 
cefuroxime and $22.80 per gram of ceftriaxone. 
Since chloramphenicol was not used at Children's Memorial 
Hospital, total costs could only be calculated for the two cephalo-
sporins used. These values, for a ten-day course of treatment in a 
ten kilogram child were calculated to be $579.10 for cefuroxime and 
$634.90 for ceftriaxone. 
DISCUSSION 
In collecting the data for this study, many similarities as well 
as some differences were noted between Primary Children's Medical 
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Center and Children's Memorial Hospital in the steps followed in the 
manipulation of an antibiotic from its initial purchase through 
administration to a patient. A brief description of the flow pattern 
at each hospital will serve to illustrate those steps and the 
division of labor involved. 
First, at Primary Children's Medical Center, drugs were ordered 
daily by the pharmacy administrator. When a drug shipment arrived, a 
technician was responsible for unpacking, pricing and shelving those 
items. Materials needed in the reconstitution of antibiotics, i.e., 
syringes and tubing, were ordered daily by another technician who 
shelved the supplies as they were received. The next step in the 
process was the medication order written by the physician. One copy 
of this order was sent to the pharmacy and one copy was given to the 
nurse on the unit. Some differences occur at this point depending on 
the antibiotic in question. 
At Primary Children's Medical Center, ampicillin was reconsti-
tuted by the nurses. The orders were processed in the pharmacy and 
medication labels were generated by the computer, and the ampicillin 
vials were then delivered to the nursing units by a pharmacist. With 
chloramphenicol and the cephalosporins, the orders were processed in 
the pharmacy, and the antibiotics were reconstituted by either a 
pharmacist or technician, and then delivered to the patient care area 
by a pharmacist. The nurses administered the antibiotics to the 
patient, and a copy of the medication administration order was sent 
to the pharmacy for a technician to charge. Overall, it appeared 
that some steps were inefficient and could have been consolidated 
both in terms of the number of tasks involved and the personnel 
performing them. Specifically, this would include the ordering of 
drugs and supplies, antibiotic reconstitution and patient charging. 
The flow pattern noted at Primary Children's Medical Center can 
be contrasted with that observed at Children's Memorial Hospital. At 
Children' Memorial Hospital a pharmacist ordered drugs and supplies 
directly from the distributor and one technician was responsible for 
pricing and shelving these items. The physician's medication order 
followed essentially the same process as described for Primary 
Children's Medical Center. A notable difference was observed with 
patient orders in the pharmacy. The pharmacist entered new orders 
into the patient's profile, and the medication labels automatically 
generated a charge to the patient. Technicians prepared all the 
antibiotics except ampicillin in the pharmacy. The medications were 
delivered to the patient care area by a technician. The nurses re-
constituted the ampicillin on the unit just prior to administration, 
and gave all of the antibiotics to complete the process. 
Evaluation of the four antibiotic regimens studied at Primary 
Children's Medical Center indicated that chloramphenicol was the most 
cost-effective drug at $390.20 for a ten-day course. Ampicillin and 
chloramphenicol have been routinely used together for 48 hours until 
culture and sensitivity data are obtained. A patient's drug regimen 
is then changed to ampicillin alone if the organism is sensitive. 
The combination of ampicillin and chloramphenicol at Primary 
Children's Medical Center cost $498.92 for a treatment course, over 
$100 more than therapy with chloramphenicol alone. The reason for 
this was that chloramphenicol alone was less expensive than ampi-
cillin alone, $39.02 versus $54.36 per day, respectively, due to 
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lower labor and supply costs. Although chloramphenicol is a general-
ly well tolerated drug, serum concentrations are still frequently 
obtained in children to help monitor for adverse reactions. For a 
child at Primary Children's Medical Center, two chloramphenicol serum 
concentrations would be drawn during a course of therapy, adding 
another $43.90 to the total cost. This is still less than the use of 
combination therapy or ceftriaxone. Since Haemophilus influenzae is 
universally sensitive to chloramphenicol in the United States, using 
this drug alone would be the most cost-effective alternative in this 
facility. Ceftriaxone, which cost $511.80 at Primary Children's 
Medical Center, is more expensive than either of the standard anti-
biotics, alone or in combination. Ceftriaxone offers some advant-
ages, having demonstrated a low adverse effect profile in clinical 
use. Twice daily dosing also minimizes the chances of medication 
error possible with the ampicillin/chloramphenicol combination. The 
high cost of the medication in this case offset savings in labor and 
supplies, and may not justify its routine use over chloramphenicol 
and/or ampicillin. 
Since chloramphenicol was not used at Children's Memorial 
Hospital, a comparison between the regimens utilizing this drug was 
not possible. Cefuroxime was determined to be the more cost-effective 
antibiotic in that institution, with a cost of $579.10 per course of 
therapy, while ceftriaxone was over $55 more expensive at $634.90. 
If one removed the antibiotic cost from the total cost equation, 
it was apparent that labor and supply costs increased proportionally 
to dosing frequency of the antibiotic studied. These data are shown 
in Tables 13 and 21. 
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One of the limitations of this study was the inability to 
compare the standard antibiotics, ampicillin and chloramphenicol, to 
ceftriaxone at Children's Memorial Hospital in Chicago. Some con-
clusions can be speculated, however actual data would have helped to 
verify the findings from Primary Children's Medical Center. Another 
limitation of the study was the small sample size in some of the 
variables measured, therefore inferential statistical analyses were 
not performed. 
CONCLUSION 
In summary, it is evident that the cost of an antibiotic alone 
is insufficient data on which to compare antibiotic regimens for 
cost-efficacy. The variables involved and their relationships are 
complex and numerous and this study attempted to identify those 
variables in two particular institutions and to find out if one 
regimen was more cost-effective than another. At Primary Children's 
Medical Center, a decreased dosing frequency resulted in a lower 
total cost for chloramphenicol when compared to ampicillin and 
chloramphenicol, but in the case of twice daily administered 
ceftriaxone, drug cost offset those savings. At Children's Memorial 
Hospital, direct comparisons were not possible, but cefuroxime 
achieved significant cost savings over ceftriaxone, again due to a 
lower drug cost. The results of this study indicate that reduced 
frequency of antibiotic administration can result in lower total 
costs of therapy, but a point is reached when high drug costs out-
weigh these savings. Further studies in this area are warranted to 
define the point at which drug cost offsets the savings achieved 




COMPONENTS OF DRUG ACQUISITION, PREPARATION, 
ADMINISTRATION, AND MONITORING 
acquisition: 
preparation: 
ordering of drug, receipt, storage 
processing of medication order, 
assembly of materials for compounding, 
reconstitution, delivery to patient 
care area 
administration: checking of order with medication, 
checking of antibiotic solution, 
infusion of antibiotic 
monitoring: checking of order for appropriateness, 
recommendation of changes, serum 
concentrations 
TABLE 2 
DEFINITIONS OF VARIOUS COST TERMS 
variable costs: amount of drug used, diluent, wastage, 
syringes, tubing 
fixed costs: inventory, capital equipment 
material costs: syringe, syringe cap, diluent, label, 
tubing, administration set, heparin flush, 
normal saline flush 
personnel costs: salaries of purchasers, technicians, 
clerks, nurses, pharmacists 
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TABLE 
ANTIBIOTIC REGIMENS TO BE COMPARED 
1) ampicillin 300 mg/kg/d intravenously every four hours plus 
chloramphenicol 100 mg/kg/d intravenously every six hours 
2) chloramphenicol 100 mg/kg/d intravenously every six hours 
3) cefuroxime 100 mg/kg/d intravenously every eight hours 
4) ceftriaxone 100 mg/kg/d intravenously every 12 hours 
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TABLE 
FIXED AND VARIABLE COMPONENTS OF THE 
PROCESSING OF AN ANTIBIOTIC 
variable: processing of medication order, reconstitution, 
delivery to patient care area, administration 
fixed: drug ordering from distributor, materials ordering 
from central supply, shelving of delivered stock, 
physician order writing 
TABLE 
HOURLY SALARIES OF PHARMACY AND NURSING PERSONNEL 
AT PRIMARY CHILDREN'S MEDICAL CENTER 
Pharmacy 
Clerk/Storeroom Technician $5.83 
Pharmacy Technician $6.65 
Pharmacist $16.05 






INDIVIDUAL ANTIBIOTIC COSTS IN DOLLARS PER DOSE AT 
PRIMARY CHILDREN'S MEDICAL CENTER 
ampicillin chloramphenicol cefuroxime ceftriaxone 
diluent 0.1033 0.0029 0.0041 0.0021 
syringe 0.04 0.04 0.06 0.04 
syringe cap - 0.06 0.06 0.06 
heparin flush 0.0983 0.1475 0.1967 0.295 
label 0.01 0.01 0.01 0.01 
saline flush 0.385 0.385 0.385 0.385 
TABLE 
DAILY ANTIBIOTIC SUPPLY COSTS AT 
PRIMARY CHILDREN'S MEDICAL CENTER 
ampicillin $3. ,82 
chloramphenicol $2. .58 
cefuroxime $2, .15 
ceftriaxone $1. .58 
TABLE 8 
INDIRECT COSTS AND WORKLOAD AT PRIMARY CHILDREN'S MEDICAL CENTER 
allocated indirect cost to pharmacy $342,562.00 
constant hours for pharmacy 24.68 
hourly wage for fixed staff $12.54 
allocated indirect cost to nursing $950,788.00 
constant hours for nursing 35.84 
hourly wage for fixed staff $9.31 
injectable medications volume 42,468 units 
total work volume 370,548 units 
unit bed capacity 30 
hospital bed capacity 180 
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TABLE 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 28 0.0256 17.84 17.38 0.90 
pricing 40 0.0494 5.83 17.38 1.15 
supplies ordering 40 0.0169 6.65 17.38 0.41 
physician order 7 0.0927 5.76 32.75 3.57 
pharmacy order entry 2 0.0405 16.05 17.38 1.35 
delivery 44 0.0113 16.05 17.38 0.38 
reconstitution 16 0.0104 11.21 32.75 0.46 
administration 16 0.1187 11.21 32.75 5.22 
charging 16 0.0172 5.83 17.38 0.40 
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TABLE 1 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 28 0.0256 17.84 17.38 0.90 
pricing 40 0.0494 5.83 17.38 1.15 
supplies ordering 40 0.0169 6.65 17.38 0.41 
physician order 7 0.0927 5.76 32.75 3.57 
pharmacy order entry 190 0.0923 16.05 17.38 3.09 
delivery 44 0.0851 16.05 17.38 2.84 
reconstitution 24 0.0148 16.05 17.38 0.49 
administration 9 0.1145 11.21 32.75 5.03 
charging 9 0.0172 5.83 17.38 0.40 
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TABLE 1 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 
WITH CEFUROXIME THERAPY AT PRIMARY CHILDREN'S MEDICAL CENTER 
AVERAGE 
NUMBER OF TIME TO LABOR INDIRECT TOTAL 








drug ordering 28 0.0256 17.84 17.38 0.90 
pricing 40 0.0494 5.83 17.38 1.15 
supplies ordering 40 0.0169 6.65 17.38 0.41 
physician order 7 0.0927 5.76 32.75 3.57 
pharmacy order entry 190 0.0923 16.05 17.38 3.09 
delivery 44 0.0851 16.05 17.38 2.84 
reconstitution 57 0.0164 16.05 17.38 0.55 
administrat ion 14 0.1455 11.21 32.75 6.40 
charging 14 0.0172 5.83 17.38 0.40 
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TABLE 1 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 28 0.0256 17.84 17.38 0.90 
pricing 40 0.0494 5.83 17.38 1.15 
supplies ordering 40 0.0169 6.65 17.38 0.41 
physician order 7 0.0927 5.76 32.75 3.57 
pharmacy order entry 190 0.0923 16.05 17.38 3.09 
delivery 44 0.0851 16.05 17.38 2.84 
reconstitution 17 0.0170 16.05 17.38 0.57 
administration 7 0.1455 11.21 32.75 6.40 
charging 7 0.0172 5.83 17.38 0.40 
30 
TABLE 13 
TOTAL DAILY COSTS OF ANTIBIOTIC THERAPY IN DOLLARS 
AT PRIMARY CHILDREN'S MEDICAL CENTER 
2 3 Labor Supplies Drug Cost Total Costs 
ampicillin 44.24 3.82 6.30 54.36 
chloramphenicol 35.64 2.58 0.80 39.02 
cefuroxime 34.01 2.15 6.60 42.76 
ceftriaxone 26.70 1.58 22.90 51.18 
includes all salaries, benefits 
includes diluent, syringe, cap, label, heparin and saline flushes 
calculated according to regimens described in Table 3: prices are 
average wholesale price 
TABLE 14 
HOURLY SALARIES OF PHARMACY AND NURSING PERSONNEL 
AT CHILDREN'S MEMORIAL HOSPITAL 
Pharmacy 
Clerk/Storeroom Technician $9.50 
Pharmacy Technician $9.16 
Pharmacist $16.75 






INDIVIDUAL ANTIBIOTIC SUPPLY COSTS IN DOLLARS 
PER DOSE AT CHILDREN'S MEMORIAL HOSPITAL 
ampicillin cefuroxime ceftriaxone 
diluent 0.0368 0.0027 0.0014 
syringe 
syringe cap 
0.12 0.16 0.12 
0.06 0.06 
heparin flush 0.035 0.07 0.105 
label 0.01 0.01 0.01 
saline flush 0.10 0.10 0.10 
TABLE 16 
DAILY ANTIBIOTIC SUPPLY COSTS IN DOLLARS 





INDIRECT COSTS AND WORKLOAD AT CHILDREN'S MEMORIAL HOSPITAL 
allocated indirect cost to pharmacy 
constant hours for pharmacy 
hourly wage for fixed staff 
allocated indirect cost to nursing 
constant hours for nursing 
hourly wage for fixed staff 
injectable medications volume 
total work volume 
unit bed capacity 













PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 51 0.0145 16.75 25.57 0.61 
pricing 51 0.0068 9.50 25.57 0.24 
* 
supplies ordering - - - - -
physician order 1 0.1183 7.30 49.72 6.75 
pharmacy order entry 50 0.1309 16.75 25.57 5.54 
delivery 47 0.0814 9.16 25.57 2.83 
reconstitution 51 0.0972 12.00 49.72 6.00 
administration 1 0.0469 12.00 49.72 2.89 
included in drug ordering 
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TABLE 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 51 0.0145 16.75 25.57 0.61 
pricing 51 0.0068 9.50 25.57 0.24 
* 
supplies ordering - - - - -
physician order 1 0.1183 7.30 49.72 6.75 
pharmacy order entry 51 0.2379 16.75 25.57 10.07 
delivery 47 0.0814 9.16 25.57 2.83 
reconstitution 213 0.0918 9.16 25.57 3.19 
checking 31 0.0065 16.75 25.57 0.28 
administration 1 0.1011 12.00 49.72 6.24 
* included in drug ordering 
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TABLE 20 
PERSONNEL TIME, LABOR COSTS AND INDIRECT COSTS ASSOCIATED 

















drug ordering 51 0.0145 16.75 25.57 0.61 
pricing 51 0.0068 9.50 25.57 0.24 
* 
supplies ordering - - - - -
physician order 1 0.1183 7.30 49.72 6.75 
pharmacy order entry 51 0.2379 16.75 25.57 10.07 
delivery 47 0.0814 9.16 25.57 2.83 
reconstitution 213 0.0918 9.16 25.57 3.19 
checking 31 0.0065 16.75 25.57 0.28 
administration 1 0.1011 12.00 49.72 6.24 
included in drug ordering 
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TABLE 21 
TOTAL DAILY COSTS OF ANTIBIOTIC THERAPY IN DOLLARS 
AT CHILDREN'S MEMORIAL HOSPITAL 
1 2 3 Labor Supplies Drug Cost Total Costs 
ampicillin 69, .31 1, ,81 7, ,20 78, ,32 
cefuroxime 49, .60 1, .21 7, .10 57, .91 
ceftriaxone 39, .90 0, .79 22, .80 63, .49 
^ includes all salaries, benefits 
2 
includes diluent, syringe, cap, label, heparin and saline flushes 
3 calculated according to regimens described in Table 3: prices are 
average wholesale price 
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